LifePak is supported by two double-blind, placebo-controlled clinical studies, a 140-subject parallel design study and a 46-subject crossover study.

• 如沛产品的效益获得两项双盲临床实验的证实，该实验计划总括了140项的平行研究以及46项的交叉研究。